E
Eugene Braunwald
Researcher at Brigham and Women's Hospital
Publications - 1758
Citations - 278949
Eugene Braunwald is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 230, co-authored 1711 publications receiving 264576 citations. Previous affiliations of Eugene Braunwald include Boston University & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Regional hemodynamic effects of prostaglandin A1 in the conscious dog
TL;DR: Prostaglandin A 1, in doses tolerated by conscious dogs, increased cardiac output and blood flow to the left coronary, mesenteric, renal, and external iliac beds, and the greatest relative increases in flow were observed in the coronary and superior mesEnteric beds, while flow increased less in the iliacs and least in the renal bed.
Journal ArticleDOI
Progress in the Noninvasive Detection of High-Risk Coronary Plaques
TL;DR: Clinicians, understandably, want to detect these plaques before they rupture so they can treat acute coronary syndromes (ACS), including sudden cardiac death.
Journal ArticleDOI
Beta-Adrenergic Receptor Blockade Propranolol and Related Drugs
TL;DR: Propranolol, the first beta-adrenergic receptor blocking agent to receive approval from the Food and Drug Administration for marketing, will soon be available for general use in the United States.
Journal ArticleDOI
Baseline Characteristics of the VANISH Cohort
Anna Axelsson Raja,Ling Shi,Sharlene M. Day,Mark W. Russell,Kenneth G. Zahka,Harry M. Lever,Steven D. Colan,Renee Margossian,E Kevin Hall,Jason R Becker,John L. Jefferies,Amit R. Patel,Lubna Choudhury,Anne M. Murphy,Charles E. Canter,Richard G. Bach,Matthew R.G. Taylor,Luisa Mestroni,Matthew T. Wheeler,Lee Benson,Anjali T. Owens,Joseph W. Rossano,Kimberly Y. Lin,Elfriede Pahl,Alexandre C. Pereira,Henning Bundgaard,Gregory D. Lewis,Jose D. Vargas,Allison L. Cirino,John J.V. McMurray,Calum A. MacRae,Scott D. Solomon,John Orav,Eugene Braunwald,Carolyn Y. Ho +34 more
TL;DR: The VANISH cohort is much larger, younger, less heterogeneous, and has less advanced disease than prior angiotensin receptor blocker trials in HCM.
Journal ArticleDOI
Heart failure: an update.
TL;DR: There appears to be a paradox between impressive reductions in mortality of individual cardiac disorders and the development of effective new therapies for HF on the one hand, with only modest changes in overall HF statistics on the other.